All Articles
PortfolioFunding
We are excited to be leading the Series B round in Solace, a groundbreaking company that is redefining how Americans access and navigate healthcare.
FirmPortfolio
Unveiling the First Cohort of Anthology Fund-Backed AI Startups
When we launched the $100 million Anthology Fund in July with our partners at Anthropic, we set out to support cutting-edge AI startups pushing…
FundingPortfolio
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and…
PerspectivePortfolio
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference
For those in healthcare, JPM provides the unofficial kickoff to every new year with a chance to recap the year before and inform our…
PortfolioFunding
Empowering Behavioral Health Providers With AI: Our Investment in Eleos
Eleos is the leader in CareOps Automation for behavioral health and joins Menlo Ventures’ exciting portfolio of healthcare software and AI companies.
FundingPortfolio
Our Investment in Cartwheel: Improving Youth Mental Health
The single greatest health concern facing American kids and teens today is a crisis in mental health.
Perspective
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world…
Portfolio
Video: Building Riva With Menlo Labs
Riva Health founders Tuhin Sinha and Dag Kittlaus discuss their critical mission to revolutionize cardiovascular healthcare; their long histories with Menlo partners Greg Yap…
PortfolioPerspective
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.
PerspectivePortfolio
Video: Early Cancer Detection With Delfi
Delfi Diagnostics has developed a test that combines ultra-low-cost sequencing and machine learning to detect cancer early.
PortfolioPerspective
Video: Reengineering Drug Discovery With Recursion
Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.
PortfolioFundingPerspective
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna
Cancer remains one of the leading causes of death in the U.S. and worldwide.